Home About Us Services Markets Online Trading Back Office Contact Us Download Mutual Fund
BACK
Your are on :   Markets   |  IPO   |  IPO SynopsisAs on: Jul 10,2025 06:59 AM
Asston Pharmaceuticals Ltd
Registered Office: 4th Flr Office No.A-431 Balaji,Bhavan Plot No.42A Sec-11 CBD, Mumbai - 400614, Maharashtra, India.
Phone : +91 22 4973 1411/+91 22 4973 1419   Fax:
Email :  info@asstonpharmaceuticals.com  
Website :  www.asstonpharmaceuticals.com
Initial public issue of up to 22,41,000 equity shares of face value of Rs.10/- each (the "Equity Shares") of Asston Pharmaceuticals Limited ("the Company" or "APL" or "the Issuer") at an issue price of Rs. [*] per equity share for cash, aggregating up to Rs. [*] crores ("Public Isue") out of which upto 1,13,000 equity shares of face value of Rs. 10/- each, at an issue price of Rs. [*] per equity share for cash, aggregating Rs. [*] crores will be reserved for subscription by the market maker to the issue (the "Market Maker Reservation Portion"). The public issue less market maker reservation portion i.e. issue of upto 21,28,000 equity shares of face value of Rs. 10/- each, at an issue price of Rs. [*] per equity share for cash, aggregating upto Rs. [*] crores is herein after referred to as the "Net Issue". The public issue and net issue will constitute 26.33 % and 25 %, respectively of the post-issue paid-up equity share capital of the company. Price Band: Rs. 115 to Rs. 123 per equity share of face value of Rs. 10 each. The floor price is 11.5 times of the face value and the cap price is 12.3 times of the face value. Bids can be made for the minimum of 1000 equity shares and in multiples of 1000 equity shares thereafter.
Issue Money Payable On
Opens On Closes On Application Allotment
09-Jul-25 11-Jul-25 115.00-123.00 0.00-0.00
Minimum Application for shares in Nos : 2000   Further Multiples of : 1000
  (Rs) Lead Managers to the Issue
Project Cost 0.00 Sobhagya Capital Options Pvt. Ltd.
Project Financed through Current Offer 25.77  
Post Issue Equity Share Capital 8.51  
Issue Price 115.00  
Projects
Funding capital expenditure requirements towards acquiring machinery in the manufacturing unit Funding the incremental working capital requirements of our company
Repayment and/or prepayment, in part or full, of certain of our outstanding borrowings availed by our company. General corporate purposes
Promoted By
Ashish Narayan Sakalkar
Saili Jayaram More
Sachin Chandrakant Badakh
Listing At
BSE - SME
Registrar to the Issue
No Data Available
Product Disclaimer Mandatory Information Privacy Policy Careers Risk disclosures Feedback Scores 2.0 Member Bank Details
"Investor Grievance" Mail your Grievance to info@lalkar.in
Important Links:   SEBI  |  NSE  |  BSE  |  MCX-SX  |  MCX   |   NCDEX  |  NSDL  |  CDSL  |  FMC   |   CDSL E-Voting  |  SMART ODR|  Saa₹thi  |  View Client Collateral Details  |  
Vernacular Languages  |  Online Freezing/Blocking Account  |  Advisory for Investor
SEBI REGISTRATION NOS - BSE CASH: INZ000269434  |  BSE FNO: INZ000269434  |  NSE CASH: INZ000269434  |  NSE FNO: INZ000269434  |  NSE CD: INZ000269434  |  MSEI CASH: INZ000269434   |   MSEI FNO: INZ000269434   |   MSEI CD: INZ000269434
AMFI NO : ARN- 19226
2010 © Lalkar Group. All rights reserved Designed, developed & powered by CMOTS Infotech(ISO 9001:2015 certified)